Ghrelin restores D1 receptor-mediated dopamine neurotransmission and enhances attentive behaviour in Mecp2 KO mice
Authors:
- Yukie KawaharaYKYukie Kawahara
- Yoshinori N. OhnishiYOYoshinori N. Ohnishi
- Tomoyuki TakahashiTTTomoyuki Takahashi
- Yuki KishikawaYKYuki Kishikawa
- Mahomi KuroiwaMKMahomi Kuroiwa
- Kotaro YugeKYKotaro Yuge
- Hiroshi KawaharaHKHiroshi Kawahara
- Yushiro YamashitaYYYushiro Yamashita
- Toyojiro MatsuishiTMToyojiro Matsuishi
- Akinori NishiANAkinori Nishi
- 8 November 2025
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1008, 178352
Abstract
No abstract availableKeywords
Funding Information
- Nurse Practitioners of Oregon (2018-02-03)
- Japan Society for the Promotion of Science (JP19H03410)
- Japan Society for the Promotion of Science (JP19K08332)
- Japan Society for the Promotion of Science (JP18K09756)
- Japan Society for the Promotion of Science (JP20K08198)
This publication has 71 references indexed in Scilit:
- Ghrelin modulates dopaminergic neuron formation and attention deficit hyperactivity disorder-like behaviors: From animals to human modelsBrain, Behavior, and Immunity, 2021
- In Situ Regulated Dopamine Transporter Trafficking: There’s No Place Like HomeNeurochemical Research, 2020
- Ghrelin in Alzheimer’s disease: Pathologic roles and therapeutic implicationsAgeing Research Reviews, 2019
- Psychomotor Dysfunction in Rett Syndrome: Insights into the Neurochemical and Circuit RootsDevelopmental Neurobiology, 2018
- Pain Experience and Expression in Rett Syndrome: Subjective and Objective Measurement ApproachesJournal of Developmental and Physical Disabilities, 2015
- Regulation of Dopamine Transporter Expression by Neuronal Activity2012
- The novel object recognition memory: neurobiology, test procedure, and its modificationsCognitive Processing, 2011
- Linking MECP2 and pain sensitivity: The example of Rett syndromeAmerican Journal of Medical Genetics Part A, 2010
- Cognitive enhancing effects of ghrelin receptor agonistsPsychopharmacology, 2009
- Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: A structure-activity studyLife Sciences, 1990